Risk Assessment of kINPen Plasma Treatment of Four Human Pancreatic Cancer Cell Lines with Respect to Metastasis

Risk Assessment of kINPen Plasma Treatment of Four Human Pancreatic Cancer Cell Lines with Respect to Metastasis

Cold physical plasma has limited tumor growth in many preclinical models and is, therefore, suggested as a putative therapeutic option against cancer. Yet, studies investigating the cells’ metastatic behavior following plasma treatment are scarce, although being of prime importance to eval...

Full description

Bibliographic Details
Main Authors: Sander Bekeschus, Eric Freund, Chiara Spadola, Angela Privat-Maldonado, Christine Hackbarth, Annemie Bogaerts, Anke Schmidt, Kristian Wende, Klaus-Dieter Weltmann, Thomas von Woedtke, Claus-Dieter Heidecke, Lars-Ivo Partecke, André Käding
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Cancers
Subjects:
cell adhesion
plasma medicine
oncology
Online Access:https://www.mdpi.com/2072-6694/11/9/1237

Internet

https://www.mdpi.com/2072-6694/11/9/1237

Similar Items